Detailed Long-term Dynamics of Neutrophil-to-Lymphocyte Ratio under Biologic Treatment Reveals Differential Effects of Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists
Author(s) -
Jochen Hoffmann,
C. Knoop,
Alexander Enk,
Eva Hadaschik
Publication year - 2021
Publication title -
acta dermato venereologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.982
H-Index - 83
eISSN - 1651-2057
pISSN - 0001-5555
DOI - 10.2340/actadv.v101.271
Subject(s) - medicine , systemic inflammation , confidence interval , neutrophil to lymphocyte ratio , odds ratio , tumor necrosis factor alpha , gastroenterology , inflammation , psoriasis , immunology , interleukin 1 receptor antagonist , interleukin , absolute neutrophil count , lymphocyte , cytokine , antagonist , toxicity , receptor antagonist , receptor , neutropenia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom